The Latin American Society of Interventional Cardiology, through the SOLACI Research Department, is conducting a survey to determine the reasons why transcatheter aortic valve replacement (TAVR) was NOT conducted in patients with severe aortic stenosis in Latin America (from January to December 2019).

Dr. Ricardo Allende, from San Luis Potosí (Mexico), and Dr. Pablo Lamelas, Head of SOLACI Research, are the main investigators behind this survey, aimed to collect data from before the COVID-19 pandemic.

Your participation is very important to us.

The survey is anonymous and completing it will not take you more than 2 minutes.

Should you not know the exact number of procedures conducted at your site, please provide an estimate.

Thank you for your participation!

Complete the survey here

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

SOLACI Research Survey | Reasons NOT to Conduct TAVR in Latin America

Subscribe to our weekly newsletter

More articles by this author

SOLACI Wishes You Happy Holidays

Condolences on the passing of Cristiam Arancibia

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

LEAVE A REPLY Cancel reply

Related Articles

Recent Articles

Transapical TMVR in High Risk Patients: Intrepid 5-Year Outcomes

EMERALD II: Non-Invasive Coronary Anatomy and Physiology (CCTA) in ACS Prediction

Impact of Balloon Post-Dilation on the Long-Term Durability of Bioprostheses after TAVR

Last News